Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwee Yong

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
British Journal of Haematology|September 9, 2016
Advances in understanding prognosis in myelomaDean Smith, Kwee Yong
BMJ (Clinical Research Ed.)|June 28, 2013
Multiple myelomaDean Smith, Kwee Yong
Blood|April 30, 2026
Immune clues to infection risk in myelomaLouise Ainley, Kwee Yong
British Journal of Haematology|May 6, 2016
Cyclin D type does not influence cell cycle response to DNA damage caused by ionizing radiation in multiple myeloma tumoursDean Smith, David Mann, Kwee Yong
Hematological Oncology|November 3, 2016
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to managementNicola Maciocia, Ashutosh Wechalekar, Kwee Yong
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Reduced intensity conditioning and allogeneic stem-cell transplantation: determining its role in multiple myelomaKarl S Peggs, Stephen Mackinnon, Kwee Yong
Journal of Multidisciplinary Healthcare|July 8, 2021
Physical Activity During and After Haematological Cancer Treatment: A Cross-Sectional Survey of Haematology Healthcare Professionals in the United KingdomOrla McCourt, Kwee Yong, Gita Ramdharry, et al.
Haematologica|November 1, 2019
Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?Monika Engelhardt, Kwee Yong, Sara Bringhen, et al.
Lancet (London, England)|December 15, 2018
Oral proteasome inhibitor maintenance for multiple myelomaNiels W C J van de Donk, Kwee Yong
Haematologica|August 30, 2008
Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal modelCharalampia Kyriakou, Neil Rabin, Arnold Pizzey, et al.
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
British Journal of Haematology|September 9, 2016
Advances in understanding prognosis in myelomaDean Smith, Kwee Yong
BMJ (Clinical Research Ed.)|June 28, 2013
Multiple myelomaDean Smith, Kwee Yong
Blood|April 30, 2026
Immune clues to infection risk in myelomaLouise Ainley, Kwee Yong
British Journal of Haematology|May 6, 2016
Cyclin D type does not influence cell cycle response to DNA damage caused by ionizing radiation in multiple myeloma tumoursDean Smith, David Mann, Kwee Yong
Hematological Oncology|November 3, 2016
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to managementNicola Maciocia, Ashutosh Wechalekar, Kwee Yong
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Reduced intensity conditioning and allogeneic stem-cell transplantation: determining its role in multiple myelomaKarl S Peggs, Stephen Mackinnon, Kwee Yong
Journal of Multidisciplinary Healthcare|July 8, 2021
Physical Activity During and After Haematological Cancer Treatment: A Cross-Sectional Survey of Haematology Healthcare Professionals in the United KingdomOrla McCourt, Kwee Yong, Gita Ramdharry, et al.
Haematologica|November 1, 2019
Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?Monika Engelhardt, Kwee Yong, Sara Bringhen, et al.
Lancet (London, England)|December 15, 2018
Oral proteasome inhibitor maintenance for multiple myelomaNiels W C J van de Donk, Kwee Yong
Haematologica|August 30, 2008
Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal modelCharalampia Kyriakou, Neil Rabin, Arnold Pizzey, et al.
Pageof 19